Literature DB >> 9525312

Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins.

C Qiu1, M B De Young, A Finn, D A Dichek.   

Abstract

The ability of adenoviral vectors to mediate efficient gene delivery both in vitro and in vivo is limited by the availability of specific cell surface receptors and alpha(v)-containing integrins. We tested whether this limitation could be overcome by enhancing viral entry with cationic liposomes. In cultured vascular smooth muscle cells, delivery of adenoviral vectors in the presence of cationic liposomes increased vector-encoded transgene expression up to 20-fold. The increase in transgene expression was associated with the formation of adenovirus-lipid aggregates and an increase in the amount of vector DNA in the cells, suggesting that enhanced viral entry was responsible for the increase in gene expression. Treatment of the cells with an RGD-containing peptide or adenovirus type 5 fiber protein did not diminish liposome enhancement of transgene expression, indicating that liposomes increase viral entry via a pathway independent of the fiber receptor and of alpha(v) integrin-assisted endocytosis. Liposomes also significantly enhanced transgene expression from adenoviral vectors delivered to cells deficient in alpha(v)-containing integrins. The magnitude of liposome enhancement of transgene expression in cultured smooth muscle cells was greatest during brief periods of virus-cell contact and at low concentrations of virus. Despite these promising in vitro results, addition of liposomes did not improve in vivo adenoviral gene delivery into injured rat carotid arteries. Liposomes can improve adenoviral gene delivery in vitro; however, application of this observation to accomplish improved in vivo gene delivery remains a challenge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525312     DOI: 10.1089/hum.1998.9.4-507

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  12 in total

1.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Reproducible transfection in the presence of carrier DNA using FuGENE6 and Lipofectamine2000.

Authors:  Takao Susa; Takako Kato; Yukio Kato
Journal:  Mol Biol Rep       Date:  2007-05-17       Impact factor: 2.316

3.  Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

Authors:  S Sanlioglu; P K Benson; J Yang; E M Atkinson; T Reynolds; J F Engelhardt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Impact of lentiviral vector-mediated transduction on the tightness of a polarized model of airway epithelium and effect of cationic polymer polyethylenimine.

Authors:  Stefano Castellani; Sante Di Gioia; Teresa Trotta; Angela Bruna Maffione; Massimo Conese
Journal:  J Biomed Biotechnol       Date:  2010-06-21

5.  Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.

Authors:  E M Lee; S H Hong; Y J Lee; Y H Kang; K C Choi; S H Choi; I H Kim; S J Lim
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-16       Impact factor: 4.553

6.  Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3.

Authors:  Yves Heremans; Mark Van De Casteele; Peter in't Veld; Gerard Gradwohl; Palle Serup; Ole Madsen; Daniel Pipeleers; Harry Heimberg
Journal:  J Cell Biol       Date:  2002-10-28       Impact factor: 10.539

7.  Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors.

Authors:  Yuka Okada; Naoki Okada; Shinsaku Nakagawa; Hiroyuki Mizuguchi; Koichi Takahashi; Nobuyasu Mizuno; Takuya Fujita; Akira Yamamoto; Takao Hayakawa; Tadanori Mayumi
Journal:  Jpn J Cancer Res       Date:  2002-04

8.  Systemically administered liposome-encapsulated Ad-PEDF potentiates the anti-cancer effects in mouse lung metastasis melanoma.

Authors:  Hua-shan Shi; Li-ping Yang; Wei Wei; Xiao-qing Su; Xiao-peng Li; Meng Li; Shun-tao Luo; Hai-long Zhang; Lian Lu; Yong-qiu Mao; Bing Kan; Li Yang
Journal:  J Transl Med       Date:  2013-04-03       Impact factor: 5.531

9.  Cationic liposome-mediated enhanced generation of human HLA-restricted RSV-specific CD8+ CTL+.

Authors:  Innocent N Mbawuike; Yongxin Zhang; Ying Wang; Ling Song
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.542

10.  Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer.

Authors:  Soo-Yeon Kim; Sang-Jin Lee; Jin-Ki Kim; Han-Gon Choi; Soo-Jeong Lim
Journal:  Int J Nanomedicine       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.